{
    "eid": "2-s2.0-85102688888",
    "title": "Positive Predictive Value and Correct Detection Rate of 18F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard",
    "cover-date": "2021-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "biochemical recurrence",
        "correct detection rate",
        "PET",
        "positive predictive value",
        "prostate-specific membrane antigen"
    ],
    "authors": [
        "Maythinee Chantadisai",
        "Gabriel Buschner",
        "Markus Kr\u00f6nke",
        "Isabel Rauscher",
        "Thomas Langbein",
        "Stephan G. Nekolla",
        "Kilian Schiller",
        "Matthias M. Heck",
        "Tobias Maurer",
        "Alexander Wurzer",
        "Hans Juergen Wester",
        "Calogero D'Alessandria",
        "Wolfgang Weber",
        "Matthias Eiber"
    ],
    "citedby-count": 4,
    "ref-count": 25,
    "ref-list": [
        "Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy",
        "Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: how much information can conventional imaging provide?",
        "Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis",
        "Single-center prospective evaluation of 68Ga-PSMA-11 PET in biochemical recurrence of prostate cancer",
        "Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology",
        "The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature",
        "Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy",
        "18F-DCFPyL PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy",
        "Detection efficacy of 18F-PSMA-1007 PET/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy",
        "18F-rhPSMA-7 PET for the detection of biochemical recurrence of prostate cancer after radical prostatectomy",
        "A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR)",
        "Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT",
        "Detection rate of 18F-labeled PSMA PET/CT in biochemical recurrent prostate cancer: a systematic review and a meta-Analysis",
        "Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial",
        "Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls",
        "Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls",
        "Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen-ligand positronemission tomography/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy",
        "68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and meta-analysis",
        "Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score",
        "Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer",
        "The role of prostate-specific antigen persistence after radical prostatectomy for the prediction of clinical progression and cancer-specific mortality in node-positive prostate cancer patients",
        "Natural history of progression after PSA elevation following radical prostatectomy",
        "Two-sided confidence intervals for the single proportion: comparison of seven methods"
    ],
    "affiliation": [
        {
            "affiliation-city": "Munich",
            "@id": "60117640",
            "affilname": "TUM Fakult\u00e4t f\u00fcr Medizin",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60117640",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Munich",
            "@id": "60019722",
            "affilname": "Technische Universit\u00e4t M\u00fcnchen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019722",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Hamburg",
            "@id": "60005036",
            "affilname": "Universit\u00e4tsklinikum Hamburg-Eppendorf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005036",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}